Advertising and Promotion Regulatory Affairs Conference

DIA’s Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices.

戻る Agenda

Session 1: FDA AdPromo Regulatory Updates from CDER, CBER, and CDRH

Session Chair(s)

Catherine Gray, PharmD

Director, Office of Prescription Drug Promotion, OMP, CDER , FDA, United States

This session will feature senior representatives from CDER, CBER, CDRH and CVM. The group will provide updates on recent FDA advertising and promotion activities, including compliance actions, process modifications, program areas and goals for 2023.

Learning Objective : At the conclusion of this session, participants should be able to:
Apply lessons from recent compliance actions to current advertising and promotion review work

Identify trends in compliance activities over the last year

Recognize significant advertising and labeling concerns that each FDA medical product Center addresses

Speaker(s)

Lisa Stockbridge, PhD

Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER, FDA, United States

Speaker

Deborah Wolf, JD

Regulatory Counsel, OPEQ , Regulatory Policy, CDRH, FDA, United States